ID29873A - Turunan amidino dan penggunaannya sebagai penghambat trombin - Google Patents
Turunan amidino dan penggunaannya sebagai penghambat trombinInfo
- Publication number
- ID29873A ID29873A IDW00200101264A ID20011264A ID29873A ID 29873 A ID29873 A ID 29873A ID W00200101264 A IDW00200101264 A ID W00200101264A ID 20011264 A ID20011264 A ID 20011264A ID 29873 A ID29873 A ID 29873A
- Authority
- ID
- Indonesia
- Prior art keywords
- treatment
- trombin
- demonstrations
- amidino
- sup
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9804313A SE9804313D0 (sv) | 1998-12-14 | 1998-12-14 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ID29873A true ID29873A (id) | 2001-10-18 |
Family
ID=20413647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW00200101264A ID29873A (id) | 1998-12-14 | 1999-12-10 | Turunan amidino dan penggunaannya sebagai penghambat trombin |
Country Status (20)
Country | Link |
---|---|
US (3) | US6750243B1 (et) |
EP (1) | EP1140820B1 (et) |
JP (1) | JP2002532467A (et) |
KR (1) | KR20010086105A (et) |
AT (1) | ATE261939T1 (et) |
AU (1) | AU753290C (et) |
BR (1) | BR9916255A (et) |
CA (1) | CA2352054C (et) |
CZ (1) | CZ20012094A3 (et) |
DE (1) | DE69915686T2 (et) |
EE (1) | EE200100315A (et) |
ID (1) | ID29873A (et) |
IL (1) | IL143384A0 (et) |
IS (1) | IS5966A (et) |
NO (1) | NO20012914L (et) |
NZ (1) | NZ512000A (et) |
PL (1) | PL348972A1 (et) |
SE (1) | SE9804313D0 (et) |
TR (1) | TR200101651T2 (et) |
WO (1) | WO2000035869A1 (et) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0001803D0 (sv) | 2000-05-16 | 2000-05-16 | Astrazeneca Ab | New compounds i |
US6433186B1 (en) | 2000-08-16 | 2002-08-13 | Astrazeneca Ab | Amidino derivatives and their use as thormbin inhibitors |
AR035216A1 (es) * | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
US7129233B2 (en) | 2000-12-01 | 2006-10-31 | Astrazeneca Ab | Mandelic acid derivatives and their use as thrombin inhibitors |
JP2004516286A (ja) | 2000-12-18 | 2004-06-03 | メルク エンド カムパニー インコーポレーテッド | ベンジルアミン誘導体およびそれのトロンビン阻害薬としての使用 |
CA2436176A1 (en) | 2001-02-09 | 2002-08-22 | Merck & Co., Inc. | Thrombin inhibitors |
AR034517A1 (es) * | 2001-06-21 | 2004-02-25 | Astrazeneca Ab | Formulacion farmaceutica |
SE0201661D0 (sv) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | New salts |
SE0201659D0 (sv) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Modified release pharmaceutical formulation |
US7781424B2 (en) * | 2003-05-27 | 2010-08-24 | Astrazeneca Ab | Modified release pharmaceutical formulation |
AU2004283751B2 (en) * | 2003-10-24 | 2011-05-19 | Exelixis, Inc. | p70S6 kinase modulators and method of use |
US7524354B2 (en) * | 2005-07-07 | 2009-04-28 | Research Foundation Of State University Of New York | Controlled synthesis of highly monodispersed gold nanoparticles |
TW200827336A (en) * | 2006-12-06 | 2008-07-01 | Astrazeneca Ab | New crystalline forms |
US20090061000A1 (en) * | 2007-08-31 | 2009-03-05 | Astrazeneca Ab | Pharmaceutical formulation use 030 |
CN104327029A (zh) * | 2014-09-21 | 2015-02-04 | 湖南华腾制药有限公司 | 一种含氧杂环化合物的制备方法 |
CN106632192A (zh) * | 2017-01-10 | 2017-05-10 | 湖南华腾制药有限公司 | 一种含氧杂环化合物的制备方法 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU178398B (en) | 1979-06-12 | 1982-04-28 | Gyogyszerkutato Intezet | Process for producing new agmatine derivatives of activity against haemagglutination |
HU192646B (en) | 1984-12-21 | 1987-06-29 | Gyogyszerkutato Intezet | Process for preparing new n-alkyl-peptide aldehydes |
AU600226B2 (en) | 1985-02-04 | 1990-08-09 | Merrell Pharmaceuticals Inc. | Novel peptidase inhibitors |
US5187157A (en) | 1987-06-05 | 1993-02-16 | Du Pont Merck Pharmaceutical Company | Peptide boronic acid inhibitors of trypsin-like proteases |
EP0362002B1 (en) | 1988-09-01 | 1995-07-26 | Merrell Dow Pharmaceuticals Inc. | HIV protease inhibitors |
ZA897515B (en) | 1988-10-07 | 1990-06-27 | Merrell Dow Pharma | Novel peptidase inhibitors |
TW201303B (et) | 1990-07-05 | 1993-03-01 | Hoffmann La Roche | |
CA2075154A1 (en) | 1991-08-06 | 1993-02-07 | Neelakantan Balasubramanian | Peptide aldehydes as antithrombotic agents |
SE9102462D0 (sv) | 1991-08-28 | 1991-08-28 | Astra Ab | New isosteric peptides |
CZ333492A3 (en) | 1991-11-12 | 1993-09-15 | Lilly Co Eli | Dipeptide of l-azetidine-2-carboxylic acids and l-argininaldehyde, process of its preparation and pharmaceutical preparation in which said dipeptide is comprised |
SE9103612D0 (sv) | 1991-12-04 | 1991-12-04 | Astra Ab | New peptide derivatives |
EP0629212B1 (en) | 1992-03-04 | 1997-10-08 | Gyogyszerkutato Intezet Kft. | New anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for the preparation thereof |
TW223629B (et) | 1992-03-06 | 1994-05-11 | Hoffmann La Roche | |
AU675981B2 (en) | 1992-12-02 | 1997-02-27 | Bristol-Myers Squibb Company | Guanidinyl-substituted heterocyclic thrombin inhibitors |
JPH06340619A (ja) | 1993-05-03 | 1994-12-13 | Bristol Myers Squibb Co | グアニジニルまたはアミジニル置換メチルアミノ複素環トロンビン抑制剤 |
SE9301916D0 (sv) * | 1993-06-03 | 1993-06-03 | Ab Astra | New peptides derivatives |
EP0648780A1 (en) | 1993-08-26 | 1995-04-19 | Bristol-Myers Squibb Company | Heterocyclic thrombin inhibitors |
TW394760B (en) | 1993-09-07 | 2000-06-21 | Hoffmann La Roche | Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same |
AU1025795A (en) | 1994-01-27 | 1995-08-03 | Mitsubishi Chemical Corporation | Prolineamide derivatives |
IL112795A (en) | 1994-03-04 | 2001-01-28 | Astrazeneca Ab | Derivatives of peptides as antithrombotic drugs, their preparation, and pharmaceutical preparations containing them |
US5705487A (en) | 1994-03-04 | 1998-01-06 | Eli Lilly And Company | Antithrombotic agents |
US5707966A (en) | 1994-03-04 | 1998-01-13 | Eli Lilly And Company | Antithrombotic agents |
US5561146A (en) | 1994-06-10 | 1996-10-01 | Bristol-Myers Squibb Company | Modified guanidino and amidino thrombin inhibitors |
DE4421052A1 (de) | 1994-06-17 | 1995-12-21 | Basf Ag | Neue Thrombininhibitoren, ihre Herstellung und Verwendung |
US5510369A (en) | 1994-07-22 | 1996-04-23 | Merck & Co., Inc. | Pyrrolidine thrombin inhibitors |
JPH11500120A (ja) * | 1995-02-17 | 1999-01-06 | ビーエーエスエフ アクチェンゲゼルシャフト | 新規なトロンビンインヒビター |
US5710130A (en) | 1995-02-27 | 1998-01-20 | Eli Lilly And Company | Antithrombotic agents |
AU698911B2 (en) | 1995-04-04 | 1998-11-12 | Merck & Co., Inc. | Thrombin inhibitors |
US5629324A (en) * | 1995-04-10 | 1997-05-13 | Merck & Co., Inc. | Thrombin inhibitors |
SA96170106A (ar) | 1995-07-06 | 2005-12-03 | أسترا أكتيبولاج | مشتقات حامض أميني جديدة |
TWI238827B (en) | 1995-12-21 | 2005-09-01 | Astrazeneca Ab | Prodrugs of thrombin inhibitors |
AU1990197A (en) | 1996-03-12 | 1997-10-01 | Bristol-Myers Squibb Company | Carbamyl guanidine and amidine prodrugs |
SE9602263D0 (sv) | 1996-06-07 | 1996-06-07 | Astra Ab | New amino acid derivatives |
US5863929A (en) | 1996-06-25 | 1999-01-26 | Eli Lilly And Company | Anticoagulant agents |
DE19632772A1 (de) | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Benzamidine |
AR013084A1 (es) * | 1997-06-19 | 2000-12-13 | Astrazeneca Ab | Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados |
SE0001803D0 (sv) * | 2000-05-16 | 2000-05-16 | Astrazeneca Ab | New compounds i |
-
1998
- 1998-12-14 SE SE9804313A patent/SE9804313D0/xx unknown
-
1999
- 1999-12-10 ID IDW00200101264A patent/ID29873A/id unknown
- 1999-12-10 EE EEP200100315A patent/EE200100315A/et unknown
- 1999-12-10 KR KR1020017007349A patent/KR20010086105A/ko not_active Application Discontinuation
- 1999-12-10 BR BR9916255-5A patent/BR9916255A/pt not_active Application Discontinuation
- 1999-12-10 EP EP99963821A patent/EP1140820B1/en not_active Expired - Lifetime
- 1999-12-10 JP JP2000588131A patent/JP2002532467A/ja active Pending
- 1999-12-10 AT AT99963821T patent/ATE261939T1/de not_active IP Right Cessation
- 1999-12-10 CZ CZ20012094A patent/CZ20012094A3/cs unknown
- 1999-12-10 DE DE69915686T patent/DE69915686T2/de not_active Expired - Lifetime
- 1999-12-10 IL IL14338499A patent/IL143384A0/xx unknown
- 1999-12-10 AU AU20187/00A patent/AU753290C/en not_active Ceased
- 1999-12-10 US US09/509,032 patent/US6750243B1/en not_active Expired - Fee Related
- 1999-12-10 CA CA002352054A patent/CA2352054C/en not_active Expired - Fee Related
- 1999-12-10 PL PL99348972A patent/PL348972A1/xx not_active Application Discontinuation
- 1999-12-10 WO PCT/SE1999/002316 patent/WO2000035869A1/en not_active Application Discontinuation
- 1999-12-10 NZ NZ512000A patent/NZ512000A/en not_active IP Right Cessation
- 1999-12-10 TR TR2001/01651T patent/TR200101651T2/xx unknown
-
2001
- 2001-06-13 IS IS5966A patent/IS5966A/is unknown
- 2001-06-13 NO NO20012914A patent/NO20012914L/no not_active Application Discontinuation
-
2004
- 2004-04-02 US US10/815,954 patent/US7241757B2/en not_active Expired - Fee Related
-
2007
- 2007-06-06 US US11/808,122 patent/US20070249578A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IS5966A (is) | 2001-06-13 |
NO20012914L (no) | 2001-08-14 |
AU2018700A (en) | 2000-07-03 |
JP2002532467A (ja) | 2002-10-02 |
NZ512000A (en) | 2003-11-28 |
DE69915686T2 (de) | 2005-02-24 |
AU753290B2 (en) | 2002-10-17 |
CA2352054C (en) | 2008-12-09 |
EP1140820B1 (en) | 2004-03-17 |
EP1140820A1 (en) | 2001-10-10 |
US20070249578A1 (en) | 2007-10-25 |
US20040186090A1 (en) | 2004-09-23 |
WO2000035869A1 (en) | 2000-06-22 |
AU753290C (en) | 2004-10-28 |
US6750243B1 (en) | 2004-06-15 |
CZ20012094A3 (cs) | 2001-11-14 |
EE200100315A (et) | 2002-02-15 |
ATE261939T1 (de) | 2004-04-15 |
CA2352054A1 (en) | 2000-06-22 |
NO20012914D0 (no) | 2001-06-13 |
US7241757B2 (en) | 2007-07-10 |
TR200101651T2 (tr) | 2001-12-21 |
DE69915686D1 (de) | 2004-04-22 |
IL143384A0 (en) | 2002-04-21 |
SE9804313D0 (sv) | 1998-12-14 |
PL348972A1 (en) | 2002-06-17 |
KR20010086105A (ko) | 2001-09-07 |
BR9916255A (pt) | 2001-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9602646D0 (sv) | Pharmaceutically-useful compounds | |
MX9804623A (es) | Precursores inactivos de farmacos inhibidores de trombina. | |
SE9602263D0 (sv) | New amino acid derivatives | |
CA2294059A1 (en) | New amidino derivatives and their use as thrombin inhibitors | |
ID29873A (id) | Turunan amidino dan penggunaannya sebagai penghambat trombin | |
ID28008A (id) | Senyawa-senyawa baru | |
CA2226256A1 (en) | New thrombin inhibitors, their preparation and use | |
ATE303988T1 (de) | Inhibitoren von serin proteasen | |
ES2183882T3 (es) | Inhibidores de trombina. | |
DE60113412D1 (de) | Inhibitoren von serin proteasen | |
DE60033689D1 (de) | Inhibitoren von serinproteasen | |
ATE355101T1 (de) | Inhibitoren von serin proteasen | |
SE0001803D0 (sv) | New compounds i | |
IL154077A0 (en) | New amidino derivatives and their use as thrombin inhibitors | |
PL369325A1 (en) | New mandelic acid derivatives and their use as thrombin inhibitors | |
TH36520A (th) | อนุพันธ์อะมิดิโนชนิดใหม่และการใช้สารเหล่านั้นเป็นตัวยับยั้งธรอมบิน |